Osteoporosis

Osteoporosis

Osteoporosis is a condition characterized by reduced bone density and quality, leading to fragile bones and an increased risk of fragility fractures. It often progresses silently until a fracture occurs, typically in the hip, spine, or wrist. Both men and women can develop osteoporosis, though white and Asian women, especially postmenopausal women, are at the highest risk. A healthy diet rich in calcium and vitamin D, regular weight-bearing exercise, and certain medications can help prevent or slow bone loss. Osteoporosis may cause fractures even from minor falls or normal daily activities.

Causes of Osteoporosis

• Estrogen deficiency following menopause
• Surgical removal of ovaries before age 45
• Aging process (bone thinning starts after age 50)
• Family history of osteoporosis
• Small body frame size
• Overactive thyroid or parathyroid glands
• Chronic calcium or vitamin D deficiency
• Long-term use of corticosteroids
• Certain medical conditions, such as rheumatoid arthritis or gastrointestinal diseases

Micropathology of Osteoarthritis

1. Articular Cartilage Degeneration

• Initial changes: Loss of proteoglycans within the cartilage matrix leads to decreased water-binding capacity and reduced resilience.
• Chondrocyte response:
• Early stage: Chondrocyte proliferation (“cloning”) occurs as a compensatory attempt at repair.
• Later stage: Chondrocyte apoptosis results in diminished maintenance of the extracellular matrix.
• Matrix alterations:
• Type II collagen fibers become disorganized and fragmented.
• Surface fibrillation develops, progressing from fine fissures to erosions, ultimately exposing the subchondral bone.
• Net effect: The cartilage becomes thinner, softer, and less capable of withstanding mechanical load.

2. Subchondral Bone Changes

• Repetitive mechanical stress leads to microfractures and the formation of subchondral cysts.
• Sclerosis (eburnation): The exposed bone surface becomes dense, smooth, and polished.
• Bone marrow edema and subsequent remodeling contribute to pain and further cartilage degeneration.

3. Osteophyte Formation

• Marginal bone proliferation at the joint edges gives rise to osteophytes (“bone spurs”).
• This process results from endochondral ossification, driven by growth factors such as TGF-β and BMPs in response to joint instability and mechanical overload.

4. Synovial and Capsular Changes

• Low-grade synovitis:
• Mild chronic inflammation characterized by macrophage and lymphocyte infiltration.
• Synovial hyperplasia and fibrosis may develop over time.
• Effusion (Joint fluid accumulation) often occurs due to irritation.

5. Meniscal and Ligamentous Degeneration (in the Knee)

• Collagen fiber fragmentation and laxity occur.
• These changes contribute to mechanical instability and accelerate articular cartilage wear.

6. Biochemical Features

• Increased activity of matrix metalloproteinases (MMPs) and aggrecanases (ADAMTS) leads to degradation of the cartilaginous matrix.
• Elevated inflammatory cytokines (IL-1β, TNF-α) inhibit tissue repair.
• Reduced anabolic growth factors (IGF-1, TGF-β) further impair matrix synthesis.

 Lifestyle Risk Factors

• Physical inactivity or sedentary lifestyle
• Tobacco use
• Regular heavy alcohol consumption
• Eating disorders or restrictive dieting

Common Signs and Symptoms of Osteoporosis

• Back pain, particularly from spinal compression fractures
• Loss of height over time
• Stooped posture or "Dowager’s Hump"
• Bone fractures from minor stresses or falls (fragility fractures)

Potential Complications

• Vertebral compression fractures leading to height loss or spinal deformities
• Hip fractures requiring surgery, with risks of loss of independence or even death in older adults
• Chronic pain and disability resulting from vertebral fractures

Diagnosis

• DEXA (Dual-energy X-ray absorptiometry) is the gold standard to assess bone mineral density (BMD)
• Conventional X-rays for detecting fractures or changes in bone structure
• Blood tests to investigate secondary causes
• QCT (Quantitative Computed Tomography) for detailed volumetric BMD measurements
• Biomarkers like C-telopeptides to evaluate bone resorption activity
• FRAX tool to estimate individual fracture risk

Osteoarthritis treatment

            For many decades of OA treatment by conventional methods such as NSAIDs, Physiotherapy and surgery ,the OA knee patients have still been increasing all over the world.  There are a lot of patients who have surgery, are facing to the chronic pain and disabilities 

            BBH has dedicated to focus on the prevention and regenerative treatment and proposed the BBH comprehensive treatment Under the 4R principle of Functional Medicine in order to preserve the healthy joint and also the regenerate the cell tissue around the joint including restoring the knee function.  as follow

• Remove: All inflammatory substance in the joint, the inflammatory conditions such as rheumatoid arthritis  Gouty arthritis or Infective arthritis The devastating factor such as overweight
• Replace: the  healthy joint fluid, Lubricant film coat
• Repair: All damage structure such as meniscus, the cruciate Ligament, the collateral ligament, and cartilage
• Rebuild: Both structural reconstruction and Biological regeneration

           By our 4R principle, which leads to the preservation of joint structure and function, as well as the regeneration of cartilage layers, meniscus, cruciate ligaments, and the surrounding soft tissue around the joints. The advanced physical therapy programme has also played an important role in the joint function restoration.

BBH Functional Rehabilitation Program

The BBH Functional Rehabilitation Program is a comprehensive, multidisciplinary program designed by rehabilitation physicians, physical therapists, and clinical specialists to support individuals with osteoporosis. The goal is to improve mobility, reduce fall risk, and enhance muscle and bone strength to promote safer daily living.